Day: November 21, 2024

New York, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) — Bleichroeder Acquisition Corp. I (Nasdaq: BACQU) (the “Company”) announced today that, commencing December 2, 2024, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and rights included in the units. The Class A ordinary shares and rights that are separated will trade on the Nasdaq Global Market under the symbols “BACQ” and “BACQR,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “BACQU.” This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be...

MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s specialty pharmacy for dispense AmplifyAssist™, Zevra’s comprehensive patient support program, in place to address access barriers CELEBRATION, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that MIPLYFFA™ (MY-PLY-FAH) (arimoclomol), the first treatment approved by the U.S. Food and Drug Administration (FDA) for the treatment of Nieman Pick disease type C (NPC), is now commercially available for dispense. MIPLYFFA is indicated for use in combination with miglustat for the treatment of neurological manifestations of NPC in adult and pediatric patients 2 years of age and older. “Early adoption...

NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it has commenced an underwritten public offering of shares of its common stock, par value $0.001 per share (“Common Stock”), and accompanying warrants to purchase shares of Common Stock, and, in lieu thereof to certain investors that so choose, pre-funded warrants to purchase shares of Common Stock and accompanying warrants to purchase shares of Common Stock. Canaccord Genuity is acting as sole book-running manager for the proposed public offering. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether...

Windsor Mills, Nov. 21, 2024 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (Nasdaq:YYAI) is pleased to announce that it has closed the acquisition of a further 50% ownership stake in Yuanyu Enterprise Management Co., Limited (YYEM), a Hong Kong-based entity focused on the global Love and Marriage sector, taking its overall stake in YYEM to 70% and received Nasdaq confirmation that post-acquisition trading of YYAI will commence at the market opening tomorrow morning on November 22, 2024. As a result of the acquisition, Connexa has now undergone a change of control, appointed new officers, new directors, and effected a spin-off of the Slinger Bag business. “We would like to thank all of our shareholders and directors for their support in the acquisition of YYEM and we wish YYEM and Connexa’s new board every success for the...

HOUSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (“Orion” and “Company”), a leading specialty construction and engineering company today announced three contract awards, two in its Marine segment and one in its Concrete segment. Each of these projects is expected to start in 2025 and will be completed within 20 months. Orion Marine was awarded a significant $88 million contract by South Carolina State Ports Authority in a competitive bid process. The project is for the Hugh K. Leatherman Terminal Wharf Extension at the Port of Charleston and Orion will self-perform the construction of 1,600 linear feet of concrete pile-supported wharf as a northward extension of the existing terminal. The scope includes the installation of precast, prestressed concrete piles, along with precast caps, deck slabs,...

OKLAHOMA CITY, Nov. 21, 2024 (GLOBE NEWSWIRE) — Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy”) announced today the pricing of its offering (the “Notes Offering”) of $750,000,000 aggregate principal amount of its 5.700% senior notes due 2035 (the “Notes”) at a price to the public of 99.609% of their face value. The Notes Offering is expected to close on December 2, 2024, subject to the satisfaction of customary closing conditions. Expand Energy intends to use the net proceeds from the Notes Offering, together with cash on hand, to fund the purchase for cash of any and all of its outstanding 5.500% senior notes due 2026 that are tendered in connection with the tender offer launched on November 20, 2024 (the “Tender Offer”), the redemption of all of its outstanding 8.375% Senior Notes due 2028 (the “Redemption”), and the...